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The sepsis-induced intramyocardial inflammatory
response results in decreased ventricular function and
myocardial damage. Chemokines such as monocyte
chemoattractant protein-1 causally contribute to
retention of intramyocardial mononuclear leukocytes
and subsequent ventricular dysfunction during
endotoxemic shock in mice and, importantly, this effect
is age dependent. It is therefore useful to consider
where monocyte chemoattractant protein-1 fits in the
complex pathway leading to ventricular dysfunction
during sepsis, why this might be an age-dependent
effect, and what this implies for care of older sepsis
patients.TLR2 and TLR4) and receptors for a variety of inflam-Slimani and colleagues report that monocyte chemoattract-
ant protein-1 (MCP-1) causally contributes to ventricular
dysfunction during endotoxemic shock in mice and, im-
portantly, this effect is age dependent [1]. It is therefore
useful to consider where MCP-1 fits in the complex path-
way leading to ventricular dysfunction during sepsis, why
this might be an age-dependent effect, and what this
implies for care of older sepsis patients.
Sepsis results in an intramyocardial inflammatory re-
sponse that leads to decreased left ventricular contrac-
tility and diastolic dysfunction [2]. If the degree of
ventricular dysfunction is minimal then the heart is able
to increase cardiac output in response to sepsis-induced
decreased systemic vascular resistance and increased
venous return, which result in the familiar hyperdynamic
septic circulation. Worsening septic shock is character-
ized by a progressive decrease in cardiac output despite
aggressive volume resuscitation and decreased left ven-
tricular afterload. In this circumstance – hypodynamicCorrespondence: Keith.Walley@hli.ubc.ca
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months following its publication. After this tim
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major causal contributor to adverse outcomes. Greater un-
derstanding of the intramyocardial inflammatory response
is important when considering mitigating strategies.
Pathogen-associated molecular patterns, such as lipo-
polysaccharide (endotoxin) from Gram-negative organisms
and peptidoglycan from Gram-positive organisms, bind
innate immune receptors including Toll-like receptors
(TLRs) [3]. TLRs are expressed on many cell types but
particularly on cell lines involved in the earliest response to
infecting pathogens, such as monocytes/macrophages.
Subsequent intracellular signaling via nuclear factor-κB
results in expression of an array of inflammatory cyto-
kines [3].
Interestingly, cardiomyocytes express TLRs [4] (notably
matory cytokines so that circulating pathogen-associated
molecular patterns and inflammatory cytokines [5] result
in an intramyocardial inflammatory response. Cardiomyo-
cytes respond with their own internal nuclear factor-κB
signaling [4,6], production of cytokines such as interleukin-
6, chemotactic cytokines (chemokines) such as MCP-1 [7]
and keratinocyte chemoattractant (KC), production of
nitric oxide [8], and upregulation of cell surface adhesion
molecules such as intracellular adhesion molecule-1 [9].
Adhesion molecules are also expressed on activated coron-
ary endothelial cells and contribute to retention of circulat-
ing leukocytes in the coronary circulation [10]. Leukocytes
are then drawn into the myocardium [11] down chemokine
gradients. Ligation of cardiomyocyte intracellular adhesion
molecule-1 by leukocytes [9,12], fibrinogen [13], and other
inflammatory molecules adversely impacts cardiomyocyte
calcium handling, which results in decreased contractility
[9]. This intramyocardial inflammatory response also trig-
gers apoptotic pathways [14] that, even in the absence of
significant end-stage cardiomyocyte apoptosis [15], can re-
sult in mitochondrial damage and dysfunction [16]. Thus,
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chemokines such as MCP-1 and KC play a causal role or
whether they are simply upregulated bystanders has not
previously been fully elucidated.
A key observation by Slimani and colleagues is that
increased myocardial MCP-1 expression resulted in in-
creased numbers of intramyocardial mononuclear leuko-
cytes and a greater decrease in ventricular contractility [1].
Fundamentally important is the further observation that
this pathway causally contributes to decreased ventricular
contractility because neutralization of MCP-1 abrogated
these effects. The observation that similar neutralization
of KC did not have the same effect provides an important
negative control. These results suggest that MCP-1 at-
tracts intramyocardial mononuclear leukocytes that then
decrease contractility, as steps in a causal pathway. These
investigators present left ventricular pressure and volume
data so we can surmise that end-systolic elastance, as a
load-independent measure of ventricular contractility,
decreased with endotoxemia and was lowest in old mice.
Nuclear factor-κB signaling leading to cytokine and
chemokine production increases with aging [17]. The
consequences of this age-related exaggerated septic in-
flammatory response have not been fully explored, yet
initial observations suggest that age-dependent increases
in signaling via TLR4 induce greater ventricular dysfunc-
tion [18]. Slimani and colleagues have confirmed and
extended these observations by considering cytokines
and chemokines that have previously been found to be
increased in the myocardium after a septic inflammatory
stimulus (tumor necrosis factor alpha, interleukin-1β,
interleukin-6, MCP-1, KC, macrophage inflammatory
protein-1α), and they nicely demonstrate that increased
MCP-1 does decrease contractility [1]. Neutralization of
MCP-1 was approximately twice as effective in improving
left ventricular ejection fraction in old mice compared
with young adult mice. Age-dependent changes in inflam-
matory cytokine and chemokine production thus have
important downstream functional effects.
These observations arise from a murine model so a
number of limitations must be recognized. The peripheral
blood leukocyte differential is quite different in mice,
where most of the circulating leukocyte count is made
up of mononuclear leukocytes. Neutrophils are under-
represented compared with humans. Thus, the intramyo-
cardial mononuclear infiltration, driven by the monocyte
chemokine MCP-1, makes sense in this murine setting
while lack of effect of KC, a granulocyte/neutrophil che-
mokine, also fits with the murine model. Nevertheless, the
current results emphasize the functional importance of
intramyocardial mononuclear leukocytes that are indeed
observed in humans [19]. This murine model used endo-
toxin administration, which is not a realistic model of
human sepsis but is an excellent tool to isolate and studyspecific pathways induced by pathogen-associated mole-
cular patterns. We should thus be circumspect in ex-
trapolating and interpreting the importance of this degree
of ventricular dysfunction, but we can be confident in
concluding that intramyocardial chemokines attracting
leukocytes contribute to ventricular dysfunction and this
response is exaggerated with aging.
In sum, these novel findings further support the notion
that the inflammatory response and its cardiovascular con-
sequences importantly change with age. Early intervention
and resuscitation aimed at reducing the proinflammatory
stimulus must continue to be emphasized in patients of
all ages.
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